Join this community!
› Share page: Email Digg del.icio.us Reddit icon StumbleUpon Technorati
Go
Search posts:

MS Related: New drugs in late-stage trials offer promise for sufferers of the chronic

Posted Jan 14 2009 8:24pm

Two Steps Forward

(Dirucotide and Fampridine-SR)

( Joy C. in Miami provided me with this soon coming article)

Mary Ellen Egan 08.07.08, 6:00 PM ET
Forbes issue date 09.01.08
{as of today (August 20, 2008), this is not yet in print}

New drugs in late-stage trials offer promise for sufferers of the chronic
and crushing disease multiple sclerosis


Robin Giese, 59, kicks off each day by getting out of her wheelchair for a half-hour ride on a stationary bike followed by 30 minutes of stretching exercises. Most afternoons she visits friends or one of of her five grandchildren, and in the evenings she and her husband, Clifford, entertain guests or go out to dinner.

Giese hasn't always been so active. She has multiple sclerosis, the degenerative disease of the central nervous system that afflicts 400,000 Americans. In MS the immune system attacks myelin, a fatty substance that protects nerve fibers much the way insulation protects electrical wires. When the unprotected nerve fibers, or axons, are damaged, signals are blocked or delayed traveling to and from the brain. This causes a variety of symptoms that can include blurred vision, incontinence, difficulty walking and paralysis.

» Read More



Want to leave a comment? Please return to this page to do so...

============================================
Post a comment
Write a comment: